← All trials
NCT02868580
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2016
- Primary completion
- Jun 1, 2018
- Completion date
- Jun 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Neuroscience Trials AustraliaLead sponsor
- The Albion CentreOverall official - principal investigator
- Calvary Health Care BethlehemCollaborator
- University of SydneyCollaborator
- Macquarie UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.